UCLA Invents Newsletter
Newsletter published by: UCLA OIP-ISR December 2014




Feb. 06, 2015
FirstFridays @ OIP
Topic:  "Startup Reality - Avoiding the Pitfalls of Starting a Business"
Speaker:  George Abe, Lecturer, UCLA Anderson

March 10, 2015
3rd Annual UCLA Medical Device Industry Partnering Conference

More Events


Keyssa Tech Logo

UCLA Startup Keyssa, Inc. Raises $47 Million
Keyssa Inc. has come out of stealth mode, announcing it has reinvented the connector, that long-overlooked but essential component in computers and mobile devices. To date, Keyssa, based in Campbell CA, has raised $47 million from investors including Intel Capital, Nantworks, Samsung, and Alsop Louie Partners.
Carbonics Wireless

Carbonics Launches from UCLA Incubator with $5.5M
Carbonics, Inc., is aiming to revolutionize traditional electronics by using nano-materials to vastly lower power consumption and improve the performance of smartphones and wearable devices. The company licenses its IP from UCLA, tracing its lineage to research funded by the SRC consortium and U.S. Air Force.
Bone Biologics logo

Bone Biologics Raises $5M to Develop NELL-1 Protein
UCLA startup Bone Biologics recently announced the completion of a $5 million funding round. The company is developing a proprietary protein for use in bone regenerative medicine using the patented recombinant human protein known as Nell-1 for use with patients undergoing spinal fusion.
Head Health

UCLA-Industry Team Wins Grant to Tackle Concussions

A team of researchers from UCLA and Architected Materials that is developing breakthrough technology to reduce the number and severity of head injuries to football players today was named a winner of the Head Health Challenge II, part of the four-year, $60 million initiative sponsored by the NFL, GE and Under Armour.

Intellectual Property Announcements

New U.S. Patents Awarded

  • 8,861,969 - All-optical AM-to-FM up-conversion for radio-over-fiber  | J.M. Liu, et al.
  • 8,860,006 - Spin transistor having multiferroic gate dielectric  | K. Wang, et al.
  • 8,858,950 - Delivery of pharmaceutical agents via the human insulin receptor  | W. Pardridge, et al.
  • 8,853,356 - Use of pentagastrin to inhibit gastric acid secretion or as a diuretic  | J. Pisegna, et al.
  • 8,852,320 - Preparation of metal-triazolate frameworks  | O. Yaghi, et al.
  • 8,846,066 - Methods and related compositions for reduction of fat and skin. . . | M. Kolodney, et al.


New UCLA Technologies Available for Licensing



     Video & Reports
    • VIDEO - How Entrepreneurs Launch Startups Based on UCLA Discoveries [view video]
    • AUTM - How Academic Technology Transfer Makes the U.S. a Better Place [view infographic]
    • STATS - California Biomedical Industry 2015 Report  [view pdf]
    Previous Issue - UCLA Invents
    • Sofie Biosciences Receives $1.5M Phase II SBIR Grant
    • Vault Nano Awarded $1M SBIR Grant for Drug Delivery
    • Blackstone Launchpad Opens for Bruin Entrepreneurs
    • UCLA App Design Competition Pairs Students, Researchers
    UCLA TechMatch Program for
    Startups and Established Companies

    Customized, automated service matches UCLA innovation with
    industry research and technology licensing interests.  Subscribe today.

    UCLA Invents Newsletter, Vol. 3, No. 4

    How to Subscribe

    Send editorial comments and corrections to:  
    Bob Nidever,  bnidever@research.ucla.edu

    Contributors: Neil Bajpayee, Howard Chang, Tara Kamin

    UCLA Invents is published by the UCLA Office of Intellectual Property & Industry Sponsored Research
    11000 Kinross Ave., Suite 200; Los Angeles, CA 90095 | tel. 310-794-0558 | http://oip.ucla.edu

    Copyright © 2014 The Regents of the University of California. All Rights Reserved.

    Share this